Press release
August 6, 2026
TriSalus Life Sciences Reports Second Quarter 2026 Results
TriSalus Life Sciences, Inc. (TLSI)
Generated second quarter revenue of $11.4 million and expanded commercial organization to support future growth and broader market penetration Maintains 2026 revenue guidance of $54 million to $57 million Hosting Conference Call and Webcast today at 4:30pm ET DENVER --(BUSINESS WIRE)--Aug.